Federal contracts

Department of Defense awarded GSK a $1.6B contract

Award

Amount: $1,597,461,996
Agency: Department of Defense
Sub-agency: Department of the Army
Recipient: Glaxosmithkline
Parent: Glaxosmithkline
Stock: GSK
Stock link: Subsidiary known by name
Signed: 21/11/15
Published: 25/04/22
Period: 21/11/15~23/09/30
Performed in: NC-4
Type: Definitive contract
Industry: Pharmaceutical preparation manufacturing
Product category: Medical and dental equipment and supplies

The amount obligated so far; it changes as the award grows.

What it buys

COVID-19 sotrovimab monoclonal antibodies

Members who traded GSK within 30 days

No member traded this stock within 30 days of the award.

Other federal contracts of GSK

			Performed in	Description
09/25	Department of Health and Human Services	$18.2MModification	NC-4	Department of Health and Human Services · Medical and dental equipment and supplies contract modification
25/09/26	Department of Health and Human Services	$27.3M	NC-4	Relenza (zanamivir) Rotadisk, 5MG
24/06/17	Department of Health and Human Services	$11.5M	NC-4	Storage and stability of AS03 adjuvant for the COVID-19 federal response
24/05/10	Department of Health and Human Services	$18.2M	NC-4	H5 pandemic readiness medical countermeasures
24/02/27	Department of Health and Human Services	$15.4M	NC-4	Fill and finish of AS03 adjuvant multi-dose vials for the COVID-19 response

All federal contracts of GSK